648 related articles for article (PubMed ID: 17530684)
1. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
2. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
3. Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.
Cadoni G; Prelajade D; Campobasso E; Calŏ L; Agostino S; Manna R; Paludetti G
Acta Otolaryngol; 2005 Oct; 125(10):1105-10. PubMed ID: 16298794
[TBL] [Abstract][Full Text] [Related]
4. Meningeal involvement in Wegener's granulomatosis.
Al Dhanhani A; Macaulay R; Maloney B; Hanly JG
J Rheumatol; 2006 Feb; 33(2):364-7. PubMed ID: 16465672
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
[TBL] [Abstract][Full Text] [Related]
6. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients.
Kamali S; Erer B; Artim-Esen B; Gul A; Ocal L; Konice M; Aral O; Inanc M
J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921
[TBL] [Abstract][Full Text] [Related]
7. [Wegener's granulomatosis in ENT: clinical presentation, diagnosis and therapy].
Tesche S; Münscher A; Metternich FU
Laryngorhinootologie; 2007 Nov; 86(11):775-9. PubMed ID: 17724622
[TBL] [Abstract][Full Text] [Related]
8. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
9. Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.
Grotz W; Wanner C; Keller E; Böhler J; Peter HH; Rohrbach R; Schollmeyer P
Clin Nephrol; 1991 Jun; 35(6):243-51. PubMed ID: 1873937
[TBL] [Abstract][Full Text] [Related]
10. Wegener's granulomatosis in a pediatric patient.
Kinn MC; Dowell M;
J Okla State Med Assoc; 2004 Jan; 97(1):36-8; quiz 39-41. PubMed ID: 14998066
[TBL] [Abstract][Full Text] [Related]
11. Wegener's granulomatosis in a pediatric patient.
Kinn MC; Dowell M
J Okla State Med Assoc; 2003 Dec; 96(12):563-5; quiz 566-8. PubMed ID: 14965025
[TBL] [Abstract][Full Text] [Related]
12. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.
Langford CA; Talar-Williams C; Sneller MC
Arthritis Rheum; 2000 Aug; 43(8):1836-40. PubMed ID: 10943874
[TBL] [Abstract][Full Text] [Related]
13. ANCA-associated vasculitis with renal involvement: an outcome analysis.
Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.
Solans-Laqué R; Bosch-Gil J; Canela M; Lorente J; Pallisa E; Vilardell-Tarrés M
Lupus; 2008 Sep; 17(9):832-6. PubMed ID: 18755865
[TBL] [Abstract][Full Text] [Related]
15. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
Gal AA; Velasquez A
Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
[TBL] [Abstract][Full Text] [Related]
16. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
Stone JH; Tun W; Hellman DB
J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
18. Wegener's granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s.
Abdou NI; Kullman GJ; Hoffman GS; Sharp GC; Specks U; McDonald T; Garrity J; Goeken JA; Allen NB
J Rheumatol; 2002 Feb; 29(2):309-16. PubMed ID: 11838848
[TBL] [Abstract][Full Text] [Related]
19. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcomes of ANCA-associated renal vasculitis.
Seck SM; Dussol B; Brunet P; Burtey S
Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
